Abstract
Purpose
The purpose of the study was to examine fatigue interference with daily living in patients with inflammatory bowel disease (IBD) and to explore relationships between severe fatigue interference and socio-demographic and clinical variables, including use of complementary and alternative medicine (CAM).
Methods
Data were collected using self-report questionnaires from adult IBD outpatients. Fatigue interference was assessed with the 5-item Fatigue Severity Scale, and scores ≥5 were defined as severe fatigue interference. CAM use was assessed with the International CAM Questionnaire. Multivariate logistic regression analysis was used to examine associations between severe fatigue interference and socio-demographic factors, clinical factors, and CAM use.
Results
In total, 428 patients had evaluable questionnaires (response rate 93 %). Severe fatigue interference was reported by 39 % of the total sample. Patients with Crohn’s disease (CD) (n = 238) were more likely than patients with ulcerative colitis (UC) (n = 190) to report severe fatigue interference (43 and 33 %, respectively, p = 0.003). In addition, patients reporting severe fatigue interference were more likely to have active disease than patients without severe fatigue interference (p < 0.001 for both diagnoses). Patients with inactive disease had scores comparable to the general population. Factors independently associated with severe fatigue interference in UC included disease activity and CAM use, while in CD they included disease activity and current smoking.
Conclusions
Severe fatigue interference is common among IBD patients with active disease. Among patients with UC, but not CD, CAM use was associated with severe fatigue interference. The relationship between fatigue interference and personal factors should be considered further in subsequent studies.
Similar content being viewed by others
References
Cosnes, J., Gower-Rousseau, C., Seksik, P., & Cortot, A. (2011). Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 140(6), 1785–1794. doi:10.1053/j.gastro.2011.01.055.
van Langenberg, D. R., & Gibson, P. R. (2010). Systematic review: Fatigue in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 32(2), 131–143. doi:10.1111/j.1365-2036.2010.04347.x.
Graff, L. A., Vincent, N., Walker, J. R., Clara, I., Carr, R., Ediger, J., et al. (2011). A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflammatory Bowel Diseases, 17(9), 1882–1889. doi:10.1002/ibd.21580.
Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. A. (2011). Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflammatory Bowel Diseases, 17(7), 1564–1572. doi:10.1002/ibd.21530.
Hauser, W., Stallmach, A., Kocalevent, R. D., Rose, M., & Fliege, H. (2005). Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis—An explorative study. GMS Psycho-Social Medicine, 2, 1–10.
Minderhoud, I. M., Oldenburg, B., van Dam, P. S., & van Berge Henegouwen, G. P. (2003). High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. American Journal of Gastroenterology, 98(5), 1088–1093. doi:10.1111/j.1572-0241.2003.07414.x.
Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. (2012). Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease. World Journal of Gastroenterology, 18(5), 445–452. doi:10.3748/wjg.v18.i5.445.
Romberg-Camps, M. J., Bol, Y., Dagnelie, P. C., Hesselink‐van de Kruijs, M. A. M., Kester, A. D., Engels, L. G., et al. (2010). Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflammatory Bowel Diseases, 16(12), 2137–2147. doi:10.1002/ibd.21285.
Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. A. (2011). Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 33(1), 106–114. doi:10.1111/j.1365-2036.2010.04498.x.
Kalaitzakis, E., Carlsson, E., Josefsson, A., & Bosaeus, I. (2008). Quality of life in short-bowel syndrome: Impact of fatigue and gastrointestinal symptoms. Scandinavian Journal of Gastroenterology, 43(9), 1057–1065. doi:10.1080/00365520802078325.
Banovic, I., Gilibert, D., & Cosnes, J. (2010). Crohn’s disease and fatigue: Constancy and co-variations of activity of the disease, depression, anxiety and subjective quality of life. Psychology, Health & Medicine, 15(4), 394–405. doi:10.1080/13548501003759155.
Bol, Y., Duits, A. A., Vertommen-Mertens, C. E., Hupperts, R. M., Romberg-Camps, M. J., Verhey, F. R., et al. (2010). The contribution of disease severity, depression and negative affectivity to fatigue in multiple sclerosis: A comparison with ulcerative colitis. Journal of Psychosomatic Research, 69(1), 43–49. doi:10.1016/j.jpsychores.2009.11.011.
Krupp, L. B., Alvarez, L. A., LaRocca, N. G., & Scheinberg, L. C. (1988). Fatigue in multiple sclerosis. Archives of Neurology, 45(4), 435–437.
Shen, J., Barbera, J., & Shapiro, C. M. (2006). Distinguishing sleepiness and fatigue: Focus on definition and measurement. Sleep Medicine Reviews, 10(1), 63–76. doi:10.1016/j.smrv.2005.05.004.
Swain, M. G. (2000). Fatigue in chronic disease. Clinical Science, 99(1), 1–8.
Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123.
Whitehead, L. (2009). The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. Journal of Pain and Symptom Management, 37(1), 107–128. doi:10.1016/j.jpainsymman.2007.08.019.
Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004). The assessment of fatigue: A practical guide for clinicians and researchers. Journal of Psychosomatic Research, 56(2), 157–170. doi:10.1016/S0022-3999(03)00371-4.
Casati, J., Toner, B. B., de Rooy, E. C., Drossman, D. A., & Maunder, R. G. (2000). Concerns of patients with inflammatory bowel disease: A review of emerging themes. Digestive Diseases and Sciences, 45(1), 26–31.
Drossman, D. A., Patrick, D. L., Mitchell, C. M., Zagami, E. A., & Appelbaum, M. I. (1989). Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Digestive Diseases and Sciences, 34(9), 1379–1386.
Czuber-Dochan, W., Dibley, L. B., Terry, H., Ream, E., & Norton, C. (2012). The experience of fatigue in people with inflammatory bowel disease: An exploratory study. Journal of Advanced Nursing,. doi:10.1111/jan.12060.
Stjernman, H., Tysk, C., Almer, S., Strom, M., & Hjortswang, H. (2010). Worries and concerns in a large unselected cohort of patients with Crohn’s disease. Scandinavian Journal of Gastroenterology, 45(6), 696–706. doi:10.3109/00365521003734141.
Wolfe, B. J., & Sirois, F. M. (2008). Beyond standard quality of life measures: The subjective experiences of living with inflammatory bowel disease. Quality of Life Research, 17(6), 877–886. doi:10.1007/s11136-008-9362-1.
Czuber-Dochan, W., Ream, E., & Norton, C. (2013). Review article: Description and management of fatigue in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 37(5), 505–516. doi:10.1111/apt.12205.
Olsen, S. A. (2009). A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occupational Therapy International, 16(1), 57–70. doi:10.1002/oti.266.
Skovgaard, L., Nicolajsen, P. H., Pedersen, E., Kant, M., Fredrikson, S., Verhoef, M., et al. (2012). Use of complementary and alternative medicine among people with multiple sclerosis in the Nordic countries. Autoimmune Diseases,. doi:10.1155/2012/841085.
Taibi, D. M., & Bourguignon, C. (2003). The role of complementary and alternative therapies in managing rheumatoid arthritis. Family and Community Health, 26(1), 41–52.
Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., & Zwahlen, M. (2012). How many cancer patients use complementary and alternative medicine: A systematic review and metaanalysis. Integrative Cancer Therapies, 11(3), 187–203. doi:10.1177/1534735411423920.
Hilsden, R. J., Verhoef, M. J., Rasmussen, H., Porcino, A., & Debruyn, J. C. (2011). Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 17(2), 655–662. doi:10.1002/ibd.21360.
Opheim, R., Bernklev, T., Fagermoen, M. S., Cvancarova, M., & Moum, B. (2012). Use of complementary and alternative medicine in patients with inflammatory bowel disease: Results of a cross-sectional study in Norway. Scandinavian Journal of Gastroenterology, 47(12), 1436–1447. doi:10.3109/00365521.2012.725092.
Siegel, K., Brown-Bradley, C. J., & Lekas, H. M. (2004). Strategies for coping with fatigue among HIV-positive individuals fifty years and older. AIDS Patient Care and STDS, 18(5), 275–288. doi:10.1089/108729104323076016.
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., et al. (2005). Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian Journal of Gastroenterology, 19(Suppl A), 5–36.
Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn’s-disease activity. Lancet, 1(8167), 514.
Walmsley, R. S., Ayres, R. C., Pounder, R. E., & Allan, R. N. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32.
Higgins, P. D., Schwartz, M., Mapili, J., Krokos, I., Leung, J., & Zimmermann, E. M. (2005). Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut, 54(6), 782–788. doi:10.1136/gut.2004.056358.
D’Haens, G., Sandborn, W. J., Feagan, B. G., Geboes, K., Hanauer, S. B., Irvine, E. J., et al. (2007). A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology, 132(2), 763–786. doi:10.1053/j.gastro.2006.12.038.
Vermeire, S., Schreiber, S., Sandborn, W. J., Dubois, C., & Rutgeerts, P. (2010). Correlation between the Crohn’s disease activity and Harvey-Bradshaw indices in assessing Crohn’s disease severity. Clinical Gastroenterology and Hepatology, 8(4), 357–363. doi:10.1016/j.cgh.2010.01.001.
Lerdal, A., Wahl, A., Rustoen, T., Hanestad, B. R., & Moum, T. (2005). Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandinavian Journal of Public Health, 33(2), 123–130. doi:10.1080/14034940410028406.
Lerdal, A., & Kottorp, A. (2011). Psychometric properties of the Fatigue Severity Scale-Rasch analyses of individual responses in a Norwegian stroke cohort. International Journal of Nursing Studies, 48(10), 1258–1265. doi:10.1016/j.ijnurstu.2011.02.019.
Mills, R., Young, C., Nicholas, R., Pallant, J., & Tennant, A. (2009). Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Multiple Sclerosis, 15(1), 81–87. doi:10.1177/1352458508096215.
Quandt, S. A., Verhoef, M. J., Arcury, T. A., Lewith, G. T., Steinsbekk, A., Kristoffersen, A. E., et al. (2009). Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). Journal of Alternative and Complementary Medicine, 15(4), 331–339. doi:10.1089/acm.2008.0521.
NCCAM (2012). What is CAM? http://nccam.nih.gov/health/whatiscam/. Accessed 10 May 2013.
Mancuso, C. A., Rincon, M., Sayles, W., & Paget, S. A. (2006). Psychosocial variables and fatigue: A longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. Journal of Rheumatology, 33(8), 1496–1502.
Kleinman, L., Zodet, M. W., Hakim, Z., Aledort, J., Barker, C., Chan, K., et al. (2000). Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Quality of Life Research, 9(5), 499–508.
Lerdal, A., Celius, E. G., & Moum, T. (2003). Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Multiple Sclerosis, 9(5), 509–514.
Omdal, R., Mellgren, S. I., Koldingsnes, W., Jacobsen, E. A., & Husby, G. (2002). Fatigue in patients with systemic lupus erythematosus: Lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. Journal of Rheumatology, 29(3), 482–486.
Hoivik, M. L., Bernklev, T., Solberg, I. C., Cvancarova, M., Lygren, I., Jahnsen, J., et al. (2012). Patients with Crohn’s disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study. Journal of Crohn’s Colitis, 6(4), 441–453. doi:10.1016/j.crohns.2011.10.001.
Graff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., et al. (2006). The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clinical Gastroenterology and Hepatology, 4(12), 1491–1501. doi:10.1016/j.cgh.2006.09.027.
Lix, L. M., Graff, L. A., Walker, J. R., Clara, I., Rawsthorne, P., Rogala, L., et al. (2008). Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflammatory Bowel Diseases, 14(11), 1575–1584. doi:10.1002/ibd.20511.
Casellas, F., Arenas, J. I., Baudet, J. S., Fabregas, S., Garcia, N., Gelabert, J., et al. (2005). Impairment of health-related quality of life in patients with inflammatory bowel disease: A Spanish multicenter study. Inflammatory Bowel Diseases, 11(5), 488–496.
Gibson, P. R., Weston, A. R., Shann, A., Florin, T. H., Lawrance, I. C., Macrae, F. A., et al. (2007). Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn’s disease. Journal of Gastroenterology and Hepatology, 22(8), 1306–1312. doi:10.1111/j.1440-1746.2007.04930.x.
Singh, S., Blanchard, A., Walker, J. R., Graff, L. A., Miller, N., & Bernstein, C. N. (2011). Common symptoms and stressors among individuals with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology, 9(9), 769–775. doi:10.1016/j.cgh.2011.05.016.
Jelsness-Jorgensen, L. P., Bernklev, T., & Moum, B. (2012). Fatigue and disease-related worries among inflammatory bowel disease patients in remission; is it a reflection of coexisting IBS-like symptoms? A short report. Journal of Psychosomatic Research, 73(6), 469–472. doi:10.1016/j.jpsychores.2012.08.009.
Talley, N. J., Abreu, M. T., Achkar, J. P., Bernstein, C. N., Dubinsky, M. C., Hanauer, S. B., et al. (2011). An evidence-based systematic review on medical therapies for inflammatory bowel disease. American Journal of Gastroenterology, 106(Suppl 1), S2–25. doi:10.1038/ajg.2011.58. quiz S26.
Loftus, E. V., Feagan, B. G., Colombel, J. F., Rubin, D. T., Wu, E. Q., Yu, A. P., et al. (2008). Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn’s disease: Patient-reported outcomes of the CHARM trial. American Journal of Gastroenterology, 103(12), 3132–3141. doi:10.1111/j.1572-0241.2008.02175.x.
Minderhoud, I. M., Samsom, M., & Oldenburg, B. (2007). Crohn’s disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue? World Journal of Gastroenterology, 13(14), 2089–2093.
Loge, J. H., Ekeberg, O., & Kaasa, S. (1998). Fatigue in the general Norwegian population: Normative data and associations. Journal of Psychosomatic Research, 45(1), 53–65.
Bultmann, U., Kant, I., Kasl, S. V., Beurskens, A. J., & van den Brandt, P. A. (2002). Fatigue and psychological distress in the working population: Psychometrics, prevalence, and correlates. Journal of Psychosomatic Research, 52(6), 445–452.
Ng, S. C., Bernstein, C. N., Vatn, M. H., Lakatos, P. L., Loftus, E. V, Jr, Tysk, C., et al. (2013). Geographical variability and environmental risk factors in inflammatory bowel disease. Gut, 62(4), 630–649. doi:10.1136/gutjnl-2012-303661.
Sirois, F. M. (2009). Editorial: Psychological adjustment to inflammatory bowel disease: The importance of considering disease activity. American Journal of Gastroenterology, 104(12), 2970–2972. doi:10.1038/ajg.2009.537.
Ranjbaran, Z., Keefer, L., Stepanski, E., Farhadi, A., & Keshavarzian, A. (2007). The relevance of sleep abnormalities to chronic inflammatory conditions. Inflammation Research, 56(2), 51–57. doi:10.1007/s00011-006-6067-1.
Young, K. E., & White, C. A. (2006). The prevalence and moderators of fatigue in people who have been successfully treated for cancer. Journal of Psychosomatic Research, 60(1), 29–38. doi:10.1016/j.jpsychores.2005.03.011.
Acknowledgments
The authors thank the following persons for including patients in the study: Elisabeth Finnes Strom, Turid Bua, Gunnhild Seim, and Elisabeth Haugen, Oslo University Hospital, Oslo; Ellen Vogt, Diakonhjemmet Hospital, Oslo; Magne Henriksen, Kjersti Eek and Elisabeth Hansen, Ostfold Hospital Trust, Fredrikstad, Sarpsborg and Moss; Roald Torp and Øystein Hovde, Innlandet Hospital Trust, Hamar and Gjovik; Trygve Hausken, Haukeland University Hospital, Bergen; Ole Hoie, Jenny Nornes and Heidi Solhaug, Southern Hospital Trust, Arendal and Kristiansand; Nina Lindheim, Telemark Hospital Trust, Skien; Venke Ekornseter Knutsen, Health Fonna, Haugesund; and Inger Johanne Bo, Stavanger University Hospital. We also thank Marte Lie Hoivik for reviewing the manuscript for intellectual content, Milada Cvancarova for statistical guidance, and Ferring Pharmaceuticals for their practical and financial help with preparation of the study.
Conflict of interest
The preparation of this study was funded in part by Ferring Pharmaceuticals. The authors have no competing interests to report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Opheim, R., Fagermoen, M.S., Bernklev, T. et al. Fatigue interference with daily living among patients with inflammatory bowel disease. Qual Life Res 23, 707–717 (2014). https://doi.org/10.1007/s11136-013-0508-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0508-4